| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/21/2001 | US6277410 Mixture comprises at least one block copolymer with ethylene(oxide) content of 50% or less, and at least one block copolymer with ethylene(oxide) content of 50% or more. |
| 08/21/2001 | US6277399 Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections |
| 08/21/2001 | US6277383 Ryegrass pollen allergen |
| 08/21/2001 | US6277381 Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| 08/21/2001 | US6277377 Using the polypeptide to screen a plurality of molecules to identify at least one molecule which specifically binds the polypeptide |
| 08/21/2001 | US6277373 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 08/21/2001 | US6277372 Porcine ventral mesencephalic cells obtained from an embryonic pig of between ages 24 and 30 of gestation from embryonic connective tissue; |
| 08/21/2001 | US6277369 The selected cells can thereafter be used as vehicles for transferring genes encoding a therapeutic protein to a mammal, including humans. |
| 08/21/2001 | US6277367 Erythropoietin solution preparation |
| 08/21/2001 | US6277356 Somatostatin peptides, use as a radiopharmaceutical, e.g. for radiotherapy of somatostatin receptor tumors, complexed with y90 |
| 08/21/2001 | CA2205555C Use of nitric oxide-releasing agents for reducing metastasis risk |
| 08/21/2001 | CA2183546C Transgenic fibrinogen |
| 08/21/2001 | CA2174315C Oligonucleotide modulation of multidrug resistance-associated protein |
| 08/21/2001 | CA2121889C Production and use of multimeric hemoglobins |
| 08/21/2001 | CA2100868C Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions forenteral and parenteral nutrition |
| 08/21/2001 | CA2060652C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 08/21/2001 | CA2052840C Lactoneotrehalose, and it's preparation and uses |
| 08/18/2001 | CA2332533A1 Novel metalloproteases having thrombospondin domains and nucleic acid compositions encoding the same |
| 08/16/2001 | WO2001059158A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/16/2001 | WO2001059152A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 08/16/2001 | WO2001059147A1 PROTEIN AND OAT β GLUCAN HYDROLYSATE FOR USE IN COSMETOLOGY AND METHOD FOR MAKING SAME |
| 08/16/2001 | WO2001059133A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | WO2001059130A2 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | WO2001059129A2 Mammalian secreted group iii phospholipase a2 |
| 08/16/2001 | WO2001059127A2 Drug metabolizing enzymes |
| 08/16/2001 | WO2001059120A2 Il-17 like molecules and uses thereof |
| 08/16/2001 | WO2001059118A1 43239, a gpcr-like molecule and uses thereof |
| 08/16/2001 | WO2001059117A2 Seven-transmembrane proteins/g-protein coupled receptors |
| 08/16/2001 | WO2001059115A2 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059114A2 Tumor suppressor gene, p47ing3 |
| 08/16/2001 | WO2001059113A2 G-protein coupled receptor proteins and nucleic acids encoding same |
| 08/16/2001 | WO2001059112A1 Anti-angiogenic intestinal peptides, zdint5 |
| 08/16/2001 | WO2001059107A1 Novel scavenger receptors |
| 08/16/2001 | WO2001059105A1 Cysteinyl leukotriene receptor 2 (cysl t2) |
| 08/16/2001 | WO2001059104A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | WO2001059103A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | WO2001059102A2 Nucleozymes with endonuclease activity |
| 08/16/2001 | WO2001059100A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | WO2001059094A2 Method of regulating transcription in a cell by altering remodeling of cromatin |
| 08/16/2001 | WO2001059088A2 Vector |
| 08/16/2001 | WO2001059087A2 Compositions for transfecting nucleic acids and their use |
| 08/16/2001 | WO2001059084A1 Protein c derivatives |
| 08/16/2001 | WO2001059080A1 18477, a human protein kinase and uses therefor |
| 08/16/2001 | WO2001059078A2 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001059065A2 Novel molecules of the card-related protein family and uses thereof |
| 08/16/2001 | WO2001059064A2 Nucleic acids, proteins, and antibodies |
| 08/16/2001 | WO2001058954A2 Trade molecules and uses related thereto |
| 08/16/2001 | WO2001058951A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/16/2001 | WO2001058950A1 Improved interleukin 10 |
| 08/16/2001 | WO2001058949A2 Heterologous polypeptide of the tnf family |
| 08/16/2001 | WO2001058948A2 USE OF NEUREGULIN-β AS AN INDICATOR AND/OR TARGET |
| 08/16/2001 | WO2001058947A1 Lipophilin complexes for use in cancer diagnosis and therapy |
| 08/16/2001 | WO2001058946A2 Polynucleotides and polypeptides encoded thereby |
| 08/16/2001 | WO2001058945A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | WO2001058943A1 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 08/16/2001 | WO2001058942A1 Antimicrobial peptides isolated from the skin of the hyperoliid frog, kassina senegalensis |
| 08/16/2001 | WO2001058941A1 Cytokine activity regulator molecules from tick salivary glands |
| 08/16/2001 | WO2001058937A2 Interferon-alpha induced genes |
| 08/16/2001 | WO2001058936A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/16/2001 | WO2001058935A2 FACTOR VII OR VIIa-LIKE MOLECULES |
| 08/16/2001 | WO2001058934A2 Kahalalide f and related compounds |
| 08/16/2001 | WO2001058933A2 Selective n-acylation of a82846 glycopeptide analogs |
| 08/16/2001 | WO2001058932A1 Cytostatic agent glycoconjugate |
| 08/16/2001 | WO2001058931A1 Method of treating disorders of the eye |
| 08/16/2001 | WO2001058929A1 Azapeptides useful in the treatment of hepatitis c |
| 08/16/2001 | WO2001058928A1 N-terminal d(-)-penicillamine peptides as aldehyde sequestration agents |
| 08/16/2001 | WO2001058927A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | WO2001058922A2 Method and compositions for treating hepatocellular cancer |
| 08/16/2001 | WO2001058921A2 Methods and compositions for generating angiostatin |
| 08/16/2001 | WO2001058918A2 Oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments |
| 08/16/2001 | WO2001058916A2 Antibodies to ccr5 |
| 08/16/2001 | WO2001058915A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/16/2001 | WO2001058891A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 08/16/2001 | WO2001058868A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 08/16/2001 | WO2001058526A2 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 08/16/2001 | WO2001058514A1 Drug delivery apparatus |
| 08/16/2001 | WO2001058493A1 Conjugates of follicle stimulating hormones |
| 08/16/2001 | WO2001058476A2 Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity |
| 08/16/2001 | WO2001058475A1 Regulation of platelet adhesion and aggregation |
| 08/16/2001 | WO2001058474A2 Microencapsulation and sustained release of biologically active agent |
| 08/16/2001 | WO2001058473A1 Method of treating or inhibiting cellular injury or cell death |
| 08/16/2001 | WO2001058472A2 Botulinum toxin pharmaceutical compositions |
| 08/16/2001 | WO2001058471A2 Novel amino acid and peptide inhibitors of staphylococcus virulence |
| 08/16/2001 | WO2001058470A2 Methods for enhancing the bioavailability of a drug |
| 08/16/2001 | WO2001058469A1 Methods for treating glaucoma |
| 08/16/2001 | WO2001058468A1 Use of relaxin to treat diseases related to vasoconstriction |
| 08/16/2001 | WO2001058467A1 Extraction of zein protein from gluten meal |
| 08/16/2001 | WO2001058451A1 Tamper-resistant oral opioid agonist formulations |
| 08/16/2001 | WO2001058447A1 Controlled-release compositions containing opioid agonist and antagonist |
| 08/16/2001 | WO2001058426A1 Sustained release composition comprising insuline like growth factor |
| 08/16/2001 | WO2001058423A1 Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases |
| 08/16/2001 | WO2001058409A2 Method of reducing aluminum levels in the central nervous system |
| 08/16/2001 | WO2001058283A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | WO2001058240A2 Photodynamic therapy for treating conditions of the eye |
| 08/16/2001 | WO2001023550A3 Pca3 messenger rna species in benign and malignant prostate tissues |
| 08/16/2001 | WO2001022983A3 Viscosity modulating substance and use thereof |
| 08/16/2001 | WO2001021645A3 Target for antiviral therapy |
| 08/16/2001 | WO2001021192A3 Methods for diagnosis and therapy of hematological and virus-associated malignancies |